Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
MadeinSingapore cancer drug ETC has achieved a new developmental milestone in achieving First Patient First Visit in Phase B The first dose of ETC has been administered to patients in this new phase of clinical testing which for the first time will l...
Takeda Pharmaceutical Company Limited announced that the US Food and Drug Administration FDA granted Breakthrough Therapy Designation for its investigational drug pevonedistat for the treatment of patients with higherrisk myelodysplastic syndromes HR...
Merck known as MSD outside the United States and Canada today announced that the US Food and Drug Administration FDA has accepted two new supplemental Biologics License Applications sBLAs for KEYTRUDA Mercks antiPD therapy The FDA has accepted and gr...
AstraZenecas Tagrisso osimertinib has been granted Breakthrough Therapy Designation BTD in the US for the adjuvant treatment of patients with earlystage IB II and IIIA epidermal growth factor receptormutated EGFRm nonsmall cell lung cancer NSCLC afte...
Roche announced that the US Food and Drug Administration FDA approved Tecentriq atezolizumab plus Cotellic cobimetinib and Zelboraf vemurafenib for the treatment of BRAF V mutationpositive advanced melanoma patients The safety profile observed in th...
Eisai Co Ltd and MSD KK a subsidiary of Merck Co Inc Kenilworth NJ USA announced today that Eisai has submitted an application in Japan for the additional indication of treatment of unresectable thymic carcinoma for multiple receptor tyrosine kinase...
Pelican BioThermal the global name in temperaturecontrolled packaging today released results of its Biopharma Cold Chain Logistics Sustainability Survey According to key opinion leaders in biopharma cold chain the biopharma industry is increasing it...
Celltrion Group announced that the UK Medicines and Healthcare products Regulatory Agency MHRA has approved the companys Clinical Trial Authorisation CTA application for a Phase I clinical trial with CTP a COVID antiviral antibody treatment candidate...
IMARA Inc a clinicalstage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin today announced the US Food and Drug Administration FDA...
Merck known as MSD outside the United States and Canada announced today that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to the hypoxiainducible factor alpha HIF inhibitor MK a novel investigational candidate...
